Literature DB >> 10598837

Quantitative proton magnetic resonance spectroscopy of cerebral metabolic disturbances in patients with MELAS.

E Wilichowski1, P J Pouwels, J Frahm, F Hanefeld.   

Abstract

Four patients with clinically and genetically defined MELAS were examined using quantitative localized proton magnetic resonance spectroscopy of the brain. Acute and chronic lesions were located in the occipital lobe and mostly characterized by strongly elevated concentrations of lactate (Lac) and glucose (GIc) as well as severely reduced concentrations of total N-acetylaspartyl compounds (tNAA, neuroaxonal markers), glutamate (Glu), and total creatine. These findings indicate a high degree of nonoxidative glycolysis reflecting either impaired oxidative energy metabolism or the use of anaerobic metabolism by infiltrating macrophages as well as damage or loss of viable neuroaxonal tissue. In contrast, glial cell populations, in particular astrocytes, seem to remain unaffected as evidenced by unchanged concentrations of myo-inositol (glial marker). In addition, all patients including one who never experienced a stroke-like episode showed elevated Lac and Glc as well as reduced tNAA and Glu in tissues appearing normal on MRI. These disturbances were stronger in cortical gray matter and cerebellum than in white matter and indicate that neuroaxonal damage is not restricted to structural lesions. The steady presence of Lac is consistent with a reduced capacity of the mitochondrial oxidative energy metabolism resulting from impaired respiratory chain function.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10598837     DOI: 10.1055/s-2007-973500

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  22 in total

Review 1.  The mitochondrial myopathy encephalopathy, lactic acidosis with stroke-like episodes (MELAS) syndrome: a review of treatment options.

Authors:  Fernando Scaglia; Jennifer L Northrop
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

2.  Transient ischemic attack-like episodes without stroke-like lesions in MELAS.

Authors:  Tadahiro Mitani; Noriko Aida; Moyoko Tomiyasu; Takahito Wada; Hitoshi Osaka
Journal:  Pediatr Radiol       Date:  2013-05-16

Review 3.  Imaging of MELAS.

Authors:  Konark Malhotra; David S Liebeskind
Journal:  Curr Pain Headache Rep       Date:  2016-09

4.  Mitochondrial dysfunction and cerebral metabolic abnormalities in patients with mitochondrial encephalomyopathy subtypes: Evidence from proton MR spectroscopy and muscle biopsy.

Authors:  Feng-Nan Niu; Hai-Lan Meng; Lei-Lei Chang; Hong-Yan Wu; Wei-Ping Li; Ren-Yuan Liu; Hui-Ting Wang; Bing Zhang; Yun Xu
Journal:  CNS Neurosci Ther       Date:  2017-07-11       Impact factor: 5.243

5.  Proton MR spectroscopy in the diagnostic evaluation of suspected mitochondrial disease.

Authors:  Doris D M Lin; Thomas O Crawford; Peter B Barker
Journal:  AJNR Am J Neuroradiol       Date:  2003-01       Impact factor: 3.825

Review 6.  Neuroimaging in mitochondrial disorders.

Authors:  Andrea L Gropman
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

7.  Brain anomalies in maternally inherited diabetes and deafness syndrome.

Authors:  I Fromont; F Nicoli; R Valéro; O Felician; B Lebail; Y Lefur; J Mancini; V Paquis-Flucklinger; P J Cozzone; Bernard Vialettes
Journal:  J Neurol       Date:  2009-06-18       Impact factor: 4.849

Review 8.  Neuroimaging of mitochondrial disease.

Authors:  Russell P Saneto; Seth D Friedman; Dennis W W Shaw
Journal:  Mitochondrion       Date:  2008-05-23       Impact factor: 4.160

Review 9.  Mitochondrial dysfunction in inherited renal disease and acute kidney injury.

Authors:  Francesco Emma; Giovanni Montini; Samir M Parikh; Leonardo Salviati
Journal:  Nat Rev Nephrol       Date:  2016-01-25       Impact factor: 28.314

10.  Cerebral metabolic abnormalities in A3243G mitochondrial DNA mutation carriers.

Authors:  Nora Weiduschat; Petra Kaufmann; Xiangling Mao; Kristin Marie Engelstad; Veronica Hinton; Salvatore DiMauro; Darryl De Vivo; Dikoma Shungu
Journal:  Neurology       Date:  2014-01-29       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.